Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.

about

ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.Garp as a therapeutic target for modulation of T regulatory cell function.Targeting TGF-β Signaling for Therapeutic Gain.

P2860

Q35872442-FEBF9FE4-D9A0-417B-BB8E-1C9D5F5B8932 Q39046334-971BE7BD-CE37-42D5-851E-1C3A96C064E6 Q39155151-FE317BE6-5C33-43B0-B8A1-C76B66CF3563

P2860

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.

Item

http://www.wikidata.org/entity/Q35840270

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Development and characterizati ...... ralize multiple TGFβ isoforms.

@ast

Development and characterizati ...... ralize multiple TGFβ isoforms.

@en

type

Item

label

Development and characterizati ...... ralize multiple TGFβ isoforms.

@ast

Development and characterizati ...... ralize multiple TGFβ isoforms.

@en

prefLabel

Development and characterizati ...... ralize multiple TGFβ isoforms.

@ast

Development and characterizati ...... ralize multiple TGFβ isoforms.

@en

P1476

Development and characterizati ...... tralize multiple TGFβ isoforms

@en

P2093

Amer M Mirza

http://www.w3.org/2001/XMLSchema#string

Llewelyn Lao

http://www.w3.org/2001/XMLSchema#string

Shireen Khan

http://www.w3.org/2001/XMLSchema#string

Steve Lee

http://www.w3.org/2001/XMLSchema#string

Toshihiko Takeuchi

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-beta signal transduction

Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor

Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family

Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding

Identification of another member of the transforming growth factor type beta gene family

The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding

Oligomeric interactions of TGF-β and BMP receptors

TGF-β - an excellent servant but a bad master

A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions

Gene expression profiling predicts clinical outcome of breast cancer

P304

389-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19420862.2015.1115166

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel H Bedinger

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26563652

http://www.w3.org/2001/XMLSchema#string

P932

4966579

http://www.w3.org/2001/XMLSchema#string

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.

about

P2860

P2860

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932